1990-2016年195个国家与地区酒精与药物使用归因的全球疾病负担
该研究基于GBD 2016数据,采用系统综述与贝叶斯元回归估计酒精、苯丙胺、大麻、可卡因和阿片类依赖的全球患病率及1990-2016年归因疾病负担。
核心结论
- 酒精与药物使用是全球疾病负担的重要贡献因素,应扩大有效干预以预防和减少物质使用疾病负担。
研究设计与样本
- 系统检索PubMed、EMBASE和PsycINFO自1980年1月1日至2016年9月7日的原始流行病学研究,无语言限制。
- 使用DisMod-MR 2.1贝叶斯元回归工具估计人群水平物质使用障碍患病率。
- 结合残疾权重计算1990-2016年YLDs、YLLs和DALYs,并采用比较评估法估计酒精与药物作为风险因素的归因负担。
- 覆盖195个国家与地区、21个区域和7个超级区域,并分析负担与SDI五分位的关系。
主要发现
- 酒精归因负担在低SDI和中高SDI国家最高,而药物归因负担随SDI水平升高而增加。
临床怎么用
- 临床应重视酒精与药物使用障碍的筛查与干预,将其作为降低全球疾病负担的重要环节。
- 需关注物质使用对其他健康结局的间接影响,归因负担中很大部分来自此效应。
- 干预策略应考虑地区SDI差异,酒精相关问题在低SDI和中高SDI国家负担更高,药物相关问题在高SDI国家负担更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alcohol and drug use can have negative consequences on the health, economy, productivity, and social aspects of communities. We aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 to calculate global and regional estimates of the prevalence of alcohol, amphetamine, cannabis, cocaine, and opioid dependence, and to estimate global disease burden attributable to alcohol and drug use between 1990 and 2016, and for 195 countries and territories within 21 regions, and within seven super-regions. We also aimed to examine the association between disease burden and Socio-demographic Index (SDI) quintiles. METHODS: We searched PubMed, EMBASE, and PsycINFO databases for original epidemiological studies on alcohol and drug use published between Jan 1, 1980, and Sept 7, 2016, with out language restrictions, and used DisMod-MR 2.1, a Bayesian meta-regression tool, to estimate population-level prevalence of substance use disorders. We combined these estimates with disability weights to calculate years of life lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 1990-2016. We also used a comparative assessment approach to estimate burden attributable to alcohol and drug use as risk factors for other health outcomes. FINDINGS: Globally, alcohol use disorders were the most prevalent of all substance use disorders, with 100·4 million estimated cases in 2016 (age-standardised prevalence 1320·8 cases per 100 000 people, 95% uncertainty interval [95% UI] 1181·2-1468·0). The most common drug use disorders were cannabis dependence (22·1 million cases; age-standardised prevalence 289·7 cases per 100 000 people, 95% UI 248·9-339·1) and opioid dependence (26·8 million cases; age-standardised prevalence 353·0 cases per 100 000 people, 309·9-405·9). Globally, in 2016, 99·2 million DALYs (95% UI 88·3-111·2) and 4·2% of all DALYs (3·7-4·6) were attributable to alcohol use, and 31·8 million DALYs (27·4-36·6) and 1·3% of all DALYs (1·2-1·5) were attributable to drug use as a risk factor. The burden of disease attributable to alcohol and drug use varied substantially across geographical locations, and much of this burden was due to the effect of substance use on other health outcomes. Contrasting patterns were observed for the association between total alcohol and drug-attributable burden and SDI: alcohol-attributable burden was highest in countries with a low SDI and middle-high middle SDI, whereas the burden due to drugs increased with higher S DI level. INTERPRETATION: Alcohol and drug use are important contributors to global disease burden. Effective interventions should be scaled up to prevent and reduce substance use disease burden. FUNDING: Bill & Melinda Gates Foundation and Australian National Health and Medical Research Council.
引用
- The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018. PMID: 30392731. doi:10.1016/S2215-0366(18)30337-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。